- MDR1/ABCB1 gene polymorphisms in patients with chronic myeloid leukemia
-
Lardo M, Castro M, Moiraghi B, Rojas F, Borda N, Rey JA, Lazarowski A
- KMID: 2172758
- Blood Res.
- 2015 Sep;50(3):154-159.
- doi: 10.5045/br.2015.50.3.154
BACKGROUND: Tyrosine kinase inhibitors (TKIs) are the recommended treatment for patients with chronic myeloid leukemia (CML). The MDR1/ABCB1 gene plays a role in resistance to a wide spectrum of drugs,... -
- CITED
-
- Close
- SHARE
-
- Close
